Skip to main content

Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia


Community-acquired pneumonia (CAP) is the leading cause of death from infectious disease in western countries and supposes an important consumption of healthcare resources. Several studies suggest that proADM is possibly as good as validated severity scores in detecting critically ill patients with CAP and probably better than other biomarkers like procalcitonin (PCT).


A single-centre prospective study between January 2009 and September 2009. Eligible patients were all consecutive adult patients, age 17 or older, admitted to the ICU with both a clinical and radiologic diagnosis of pneumonia as per Fine and colleagues, and meeting criteria for severe sepsis or septic shock. Venous blood samples were obtained at admission on the ICU and collected in tubes containing EDTA. After centrifugation, they were kept frozen at -80°C until assayed. MR-proADM, PCT and C-reactive protein (CRP) were measured in these samples.


In all cases, proADM values at ICU admission were pathological. ProADM consistently rose as PSI class advanced from II to V (P = 0.02). Differences across PSI class were not significant for CRP (P = 0.73) and PCT (P = 0.12). Median proADM levels were higher (P = 0.007) in hospital nonsurvivors (8.1 ± 9.2 nmol/l) versus survivors (3.0 ± 3.2 nmol/l). These differences were also significant with respect to ICU mortality (9.9 ± 10.4 vs. 3.2 ± 3.2 nmol/l; P = 0.001). The receiver-operating characteristic curve for proADM yielded an AUC of 0.72; better than the AUC for PCT and CRP (0.40 and 0.44, respectively) and similar to PSI (0.74). The optimal prognostic cut-off (maximum combined sensitivity and specificity) related to in-hospital mortality for proADM was 4.86 nmol/l, with a sensitivity of 0.53, specificity of 0.84, positive likelihood ratio of 3.39, negative likelihood ratio of 0.56, positive predictive value of 64.3 and negative predictive value of 77.1. Those patients with a proADM level higher than 4.86 nmol/l on ICU admission had an in-hospital mortality significantly higher than those with lower value.


ProADM levels on ICU admission predict the severity and outcome of severe sepsis and septic shock CAP with a similar prognostic accuracy as the PSI and a higher prognostic accuracy compared with commonly measured laboratory parameters.

Author information

Authors and Affiliations


Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Suberviola, B., Castellanos, A., Astudillo, L.G. et al. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia. Crit Care 15 (Suppl 1), P276 (2011).

Download citation

  • Published:

  • DOI:


  • Septic Shock
  • Severe Sepsis
  • Procalcitonin
  • Negative Likelihood Ratio
  • Positive Likelihood Ratio